In fact, the IGCLC guidelines are very clear about not considering the intestinal type for CDH1/CTNNA1 testing, as this cancer type is not part of the syndrome [2], but they provide no guidance as regards to mixed GC. This evidence concerns the gene CTNNA1 and cancer.